Bioneer Corporation Stock

Equities

A064550

KR7064550007

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
30,100 KRW -1.15% Intraday chart for Bioneer Corporation -0.99% -9.61%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 218B 160M Sales 2023 263B 193M Capitalization 859B 630M
Net income 2022 12.08B 8.85M Net income 2023 -10.59B -7.76M EV / Sales 2022 3.24 x
Net cash position 2022 52.16B 38.24M Net cash position 2023 47.19B 34.59M EV / Sales 2023 3.09 x
P/E ratio 2022
62.8 x
P/E ratio 2023
-81.2 x
Employees 606
Yield 2022 *
-
Yield 2023
-
Free-Float 81.97%
More Fundamentals * Assessed data
Dynamic Chart
Bioneer Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
AFCAGRO Biotech Limited Enters into an Agreement with Bioneer Corporation to Produce Molecular Diagnostic Kits CI
Bioneer Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bioneer Corporation announced that it has received KRW 999.989452 million in funding from IBK Capital Corporation CI
Bioneer Corporation announced that it expects to receive KRW 999.989452 million in funding from IBK Capital Corporation CI
Bioneer Corporation announced that it has received KRW 20 billion in funding from a group of investors CI
Bioneer Corporation announced that it expects to receive KRW 20 billion in funding from a group of investors CI
Bioneer Corporation(KOSDAQ:A064550) added to S&P Global BMI Index CI
Bioneer Corporation announced that it has received KRW 18.499955 billion in funding CI
Bioneer Corporation announced that it expects to receive KRW 18.499955 billion in funding CI
Bioneer Corporation(KOSDAQ:A064550) dropped from S&P Global BMI Index CI
Bioneer Corporation announced that it has received KRW 4.9000392 billion in funding from GK Asset Co.,Ltd. CI
Bioneer Corporation announced that it expects to receive KRW 4.9000392 billion in funding from GK Asset Co.,Ltd. CI
Bioneer Corporation(KOSDAQ:A064550) added to S&P Global BMI Index CI
Bioneer Corporation announced that it has received KRW 5 billion in funding from LB Investment Inc., KDB Capital Corporation, Investment Arm, IBK Capital Corporation, Anda Investment Partners, and another investor. CI
More news
1 day-1.15%
1 week-0.99%
Current month-0.99%
1 month+14.23%
3 months+14.89%
6 months-6.08%
Current year-9.61%
More quotes
1 week
29 550.00
Extreme 29550
30 650.00
1 month
25 550.00
Extreme 25550
31 650.00
Current year
23 950.00
Extreme 23950
36 350.00
1 year
23 950.00
Extreme 23950
62 100.00
3 years
16 700.00
Extreme 16700
98 800.00
5 years
5 000.00
Extreme 5000
98 800.00
10 years
4 355.00
Extreme 4355
98 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-07-31
Director/Board Member 60 03-02-28
Director/Board Member 61 00-01-31
Members of the board TitleAgeSince
Chief Executive Officer 62 92-07-31
Director/Board Member 59 97-04-30
Director/Board Member 61 00-01-31
More insiders
Date Price Change Volume
24-05-08 30,100 -1.15% 91 667
24-05-08 30,450 +1.67% 131,619
24-05-07 29,950 +0.17% 138,017
24-05-03 29,900 +0.84% 137,664
24-05-02 29,650 -2.47% 304,564

End-of-day quote Korea S.E., May 08, 2024

More quotes
BIONEER CORPORATION is a Korea-based company engaged in the biotechnology business. The Company mainly focuses on the development of deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits and other services, such as DNA and ribonucleic acid (RNA) amplification products, Oligo synthesis and reagents, gene synthesis services, gene expressions, protein expressions and purifications, genomics services, human diagnostics kits, veterinary diagnostics kits and others. It also provides DNA devices, including DNA extraction, amplification and quantitative analysis devices and other DNA diagnostic devices, and supplies for tests and others. In addition, it provides equipment and supplies used for biotechnology research. The Company operates its business within domestic market and in overseas markets, including America, China, Japan, India, Africa and others.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A064550 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW